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Abstract: The human immune system consists of a large number of T cells capable of recognizing and
responding to antigens derived from various sources. The development of peptide-major histocompatibility
(p/MHC) tetrameric complexes has enabled the direct detection of these antigen-specific T cells. With the
goal of increasing throughput and multiplexing of T cell detection, protein microarrays spotted with defined
p/MHC complexes have been reported, but studies have been limited due to the inherent instability and
reproducibility of arrays produced via conventional spotted methods. Herein, we report on a platform for
the detection of antigen-specific T cells on glass substrates that offers significant advantages over existing
surface-bound schemes. In this approach, called “Nucleic Acid Cell Sorting (NACS)”, single-stranded DNA
oligomers conjugated site-specifically to p/MHC tetramers are employed to immobilize p/MHC tetramers
via hybridization to a complementary-printed substrate. Fully assembled p/MHC arrays are used to detect
and enumerate T cells captured from cellular suspensions, including primary human T cells collected from
cancer patients. NACS arrays outperform conventional spotted arrays assessed in key criteria such as
repeatability and homogeneity. The versatility of employing DNA sequences for cell sorting is exploited to
enable the programmed, selective release of target populations of immobilized T cells with restriction
endonucleases for downstream analysis. Because of the performance, facile and modular assembly of
p/MHC tetramer arrays, NACS holds promise as a versatile platform for multiplexed T cell detection.
Introduction
T cells constitute an important part of the acquired immune
system. They recognize a diversity of antigens through the
highly variable, heterodimeric T cell receptor protein (TCR),
with approximately 107 different antigen specificities.1 The
initiation of the T cell immune response is triggered by the
engagement of the TCR with processed antigenic peptides (e.g.,
from a bacterial pathogen) that are bound to Major Histocom-
patibility Complex (p/MHC) molecules presented on the surface
of antigen presenting cells (APCs), leading to downstream T
cell proliferation and maturation into effector populations. After
the pathogen has been cleared, a subset of the activated T cells
transition into memory cells, providing the immune system with
the capacity for rapid response toward previously encountered
pathogens. As a consequence, an individual’s collection of T
cells and their antigen specificities, collectively called the T cell
repertoire, is an evolving, extensive repository of cellular
immune responses against self-and foreign antigens. It is of
fundamental and therapeutic importance to detect and survey
these T cell populations.
The development of soluble p/MHC tetramers for labeling
antigen-specific T cells has enabled the direct phenotypic
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analysis of antigen-specific T cell populations with flow
cytometry.2 Conventionally, p/MHC tetramers are prepared by
mixing enzymatically biotinylated p/MHC molecules with
preparations of streptavidin(SA)-fluorophore conjugates. While
p/MHC monomers have low affinities,2,3 their tetramer coun-
terparts exhibit much higher avidity, permitting T cell detection
via flow cytometry to become a standard assay. However,
because p/MHC tetramer-stained T cell populations are encoded
optically (i.e., one unique fluorophore required per p/MHC
specificity), the number of antigen-specificities that can be
interrogated simultaneously within a population is limited by
spectral overlap. In addition, serial flow cytometry detection of
distinct antigen-specific T cells is generally restricted by sample
size. Efforts to increase the degree of multiplexing generally
revolve around polychromatic flow cytometry utilizing quantum
dots.4,5 However, cost, sample preparation time, and color
compensation complexity also increase correspondingly.
As an alternative to flow cytometry, several groups have
reported microarray-based T cell detection schemes, in which
collections of p/MHC complexes are printed on a supporting
substrate.6-9 A population of cells is applied directly to the
p/MHC array where target antigen-specific T cells bind to
regions spotted with the cognate p/MHC and are detected
optically. Analogous to DNA and protein microarrays, the
readout of such assays is dependent on location rather than
distinct fluorescent signals, thus potentially increasing the degree
of multiplexing.
A factor that needs to be addressed before p/MHC arrays are
used for broader studies and applications concerns the reproduc-
ibility and robustness of p/MHC arrays produced by spotting
onto treated and/or derivatized surfaces. Ideally, p/MHC com-
plexes should be immobilized such that their functional con-
formations are preserved. Analogous protein arrays produced
via antibody adsorption to unmodified and derivatized surfaces
can suffer from surface induced effects, including protein
denaturation and protein adsorption in inactive orientations.10-12
To circumvent such problems, customized surfaces and rela-
tively mild chemistries for protein immobilization have been
developed.13-18 However, often the surface that meets the
demands of the application requires a high level of technical
expertise and/or is limited in accessibility.19
We report here on the method of Nucleic Acid Cell Sorting
(NACS), which is based upon the design and application of
nucleic acid assembled p/MHC tetramer arrays for multiplexed
sorting of antigen-specific T cells. For NACS, p/MHC tetramers
of distinct specificities are conjugated to unique sequences of
ssDNA in a site-specific fashion. A collection of ssDNA-tagged
p/MHC complexes is then self-assembled by DNA hybridization
onto a glass slide printed with the cDNA sequences. Fully
assembled p/MHC tetramer arrays are used to sort mixed
(2) Altman, J. D.; Moss, P. A. H.; Goulder, P.J. R.; Barouch, D. H.;
McHeyzer-Williams, M. G.; Bell, J. I.; McMichael, A. J.; Davis, M. M.
Science 1996, 274, 94–96.
(3) Matsui, K.; Boniface, J. J.; Steffner, P.; Reay, P. A.; Davis, M. M.
Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 12862–12866.
(4) McLaughlin, B. E.; Baumgarth, N.; Bigos, M.; Roederer, M.; DeRosa,
S. C.; Altman, J. D.; Nixon, D. F.; Ottinger, J.; Oxford, C.; Evans,
T. G.; Asmuth, D. M. Cytometry A 2008, 73, 400–4010.
(5) Chattopadhyay, P. K.; Price, D. A.; Harper, T. F.; Betts, M. R.; Yu,
J.; Gostick, E.; Perfetto, S. P.; Goepfert, P.; Koup, R. A.; De Rosa,
S. C.; Bruchez, M. P.; Roederer, M. Nat. Med. 2006, 12, 972–977.
(6) Chen, D. S.; Soen, Y.; Stuge, T. B.; Lee, P. P.; Weber, J. S.; Brown,
P. O.; Davis, M. M. PLoS Med. 2005, 2, 1018–1030.
(7) Soen, Y.; Chen, D. S.; Kraft, D. L.; Davis, M. M.; Brown, P. O. PLoS
Biol. 2003, 1, 429–438.
(8) Stone, J. D.; Demkowicz, W. E.; Stern, L. J. Proc. Natl. Acad. Sci.
U.S.A. 2005, 102, 3744–3749.
(9) Deviren, G.; Gupta, K.; Paulaitis, M. E.; Schneck, J. P. J. Mol.
Recognit. 2007, 20, 32–38.
(10) Haab, B. B.; Dunham, M. J.; Brown, P. O. Genome Biol. 2001, 2,
1–13.
(11) Butler, J. E.; Ni, L.; Brown, W. R.; Joshi, K. S.; Chang, J.; Rosenberg,
B.; Voss Jr, E. W. Mol. Immunol. 1993, 30, 1165–1175.
(12) Butler, J. E.; Ni, L.; Nessler, R.; Joshi, K. S.; Suter, M.; Rosenberg,
B.; Chang, J.; Brown, W. R.; CantareroButler, L. A. J. Immunol.
Methods 1992, 150, 77–90.
(13) MacBeath, G.; Schreiber, S. L. Science 2000, 289, 1760–1763.
(14) Lesaicherre, M. L.; Lue, Y. P. R.; Chen, G. Y. J.; Zhu, Q.; Yao, Q.
J. Am. Chem. Soc. 2002, 124, 8786.
(15) Peluso, P.; Wilson, D.; Do, D.; Tran, H.; Venkatasubbaiah, M.; Quincy,
D.; Heidecker, B.; Poindexter, K.; Tolani, N.; Phelan, M.; Witte, K.;
Jung, L.; Wagner, P.; Nock, S. Anal. Biochem. 2003, 312, 113–124.
(16) Kwon, Y.; Han, Z.; Karatan, E.; Mrksich, M.; Kay, B. K. Anal. Chem.
2004, 76, 5713–5720.
(17) Arenkov, P.; Kukhtin, A.; Gemmel, A.; Voloshchuk, S.; Chupeeva,
V.; Mirzabekov, A. Anal. Biochem. 2000, 278, 123–131.
(18) Kiyonaka, S.; Sada, K.; Yoshimura, I.; Shinkai, S.; Kato, N.; Hamachi,
I. Nat. Mater. 2004, 3, 58–64.
(19) For example, the polyacrylamide surface employed by Davis and
co-workers6,7 has been discontinued from the manufacturer (Perkin
Elmer).
Figure 1. Self-assembled ssDNA-p/MHC tetramer arrays for multiplexed sorting of antigen-specific cells. ssDNA-tagged p/MHC tetramers are produced
by coupling ssDNA site-specifically to SAC prior to exposure to molar excess of biotinylated p/MHC monomers. p/MHC tetramer arrays are formed by
pooling ssDNA-p/MHC tetramers of select specificity and hybridization to a complementary printed ssDNA microarray. T cells expressing the cognate TCR
are detected by binding to the surface confined tetramer.
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populations of antigen-specific T cells (Figure 1). This strategy
of using DNA pendants as molecular linkages20-25 is simple
and highly modular. Most importantly, T cell array binding is
optimized by utilizing cysteine-engineered streptavidin (SAC)
for ssDNA-p/MHC tetramer production, resulting in NACS
p/MHC arrays that outperform conventional spotted arrays
assessed by performance criteria such as reproducibility and
homogeneity. The versatility of using DNA tags is also exploited
to enable selective detachment of T cells with restriction
endonucleases. Demonstrative experiments regarding NACS
sensitivity, multiplexing and limit of detection are performed
with cell lines and finally with T cells isolated from cancer
patients.
Results and Discussion
Rational Design of ssDNA-Encoded p/MHC Tetramers. The
standard scaffold most frequently used to assemble p/MHC
monomers into tetramers is a SA-phycobiliprotein (using the
protein fluorophores phycoerythrin (PE) or allophycocyanain
(APC)) conjugate. SA-phycobiliprotein conjugates are produced
via chemical cross-linking, which means that most functional
groups are exhausted and/or altered, which prohibits the
conjugation of ssDNA. In addition, the attachment of molecular
fluorophores to native SA reduces the binding capacity for
biotin, an effect attributed to the modification of lysine 121 that
occurs with amide coupling strategies. This residue is in close
proximity to the ligand binding pockets.26,27 To circumvent this,
Altman and co-workers26 employed a recombinant mutant of
SA for fluorescent p/MHC tetramer preparations. This variant
incorporates a cysteine residue at the carboxy-terminus,28 a site
removed from the biotin binding pocket. The conjugation of
cysteine-reactive maleimide derivatives is restricted to the
C-terminus because cysteine residues are absent in native SA.
We expressed SAC, coupled the protein with 5′-maleimide
ssDNA, and verified the formation of conjugates with mobility
shift assays (Figure S1A,B of the Supporting Information). In
parallel, ssDNA was coupled to native SA for direct comparison.
To test biotin binding capacity, SAC-oligo conjugates were
probed with 2-(4′-Hydroxyazobenzene) benzoic acid (HABA),29
a molecular mimic of biotin with distinct optical density
coefficients dependent on whether biotin is bound to SA. A
biotin:SA molar ratio of association significantly below 4 in
the assay would indicate a reduction in biotin binding capacity.
Conjugates derived from native SA were greater than one full
unit below the expected value (2.86 versus 4.0), while conjugates
formed with SAC maintained near optimal (3.7) binding capacity
(Figure S1C of the Supporting Information). These conjugates
were then tested across four different monoclonal T cell
populations (two human TCR-transduced cell lines and two
murine TCR-transgenic splenocyte cell suspensions). ssDNA-
tagged SAC constructs had markedly higher cell capture
efficiencies compared with p/MHC tetramers prepared with
native SA (Figure S2 of the Supporting Information). All
subsequent NACS tetramers were prepared with the SAC
variant.
Performance of p/MHC Arrays Produced via DNA
Immobilization and Direct Spotting. We compared the perfor-
mance of NACS with conventional spotting strategies on various
model substrates. The substrates were selected to represent the
spectrum of surface chemistries typically used to immobilize
proteins (covalent, electrostatic, hydrophobic, and hydrophilic
adsorption). Serial dilutions of a fluorescent p/MHC tetramer,
MART-1, were spotted on the substrates according to manu-
facturer’s instructions. JurkatR-MART-1 T cells (Jurkat human T
cells transduced with the TCR30 specific for MART-1) were
applied to the array and representative images collected (Figure
2A) and quantified (Figure 2B). We observed little to no T cell
capture (electrostatic, hydrophilic) or significant noise (hydro-
phobic) on the majority of the surfaces investigated compared
to NACS arrays immobilized with identical concentrations of
p/MHC tetramers. T cell binding was observed on one surface
(covalent) but cell capture was highly variable as evidenced by
both intraspot and interspot heterogeneity and cross experimental
variation (Figure S3 of the Supporting Information). Moreover,
to achieve equivalent T cell capture densities, NACS p/MHC
arrays required >5× less material than covalent immobilization.
(p/MHC monomer at half max K1/2 ) 1.1 ng for NACS and
5.7 ng for covalent immobilization).
The performance and reproducibility of NACS p/MHC arrays
is markedly improved and represents an integral step toward
expanding array-based T cell detection schemes for broader
applications. This likely has a few causes. First, surface-tethered
ssDNA-p/MHC tetramers may enjoy greater orientational
freedom at the surface/solution interface compared with ad-
sorbed proteins which are required to conform to the surface.
This effect may increase the density of functional protein and
consequently reduce the amount of material required for array
production. Second, the hydration state of the environment
during the production and subsequent storage of protein arrays
is an important factor for array reproducibility.10,13,18 This effect
is minimized with NACS because DNA chips can be printed
and stored dry for extended periods of time and ssDNA-tagged
p/MHC tetramer arrays are self-assembled in solution im-
mediately prior to an experiment.
NACS Specificity and Limit of Detection. To evaluate the
specificity of p/MHC array assembly and T cell sorting, a
ssDNA-p/MHC tetramer, tyrosinase, with pendant DNA se-
quence A′ was hybridized to a DNA microarray printed with
the complementary strand (A) along with two additional distinct
sequences (designated B and C). A homogeneous population
of JurkatR-Tyr cells (Jurkat cells transduced with a TCR specific
for tyrosinase)31 was then applied to the array. JurkatR-Tyr T cells
localized to the complementary spots (A) containing the
(20) Bailey, R. C.; Kwong, G. A.; Radu, C. G.; Witte, O. N.; Heath, J. R.
J. Am. Chem. Soc. 2007, 129, 1959–1967.
(21) Boozer, C.; Ladd, J.; Chen, S. F.; Jiang, S. T. Anal. Chem. 2006, 78,
1515–1519.
(22) Niemeyer, C. M. Nano Today 2007, 2, 42–52.
(23) Chandra, R. A.; Douglas, E. S.; Mathies, R. A.; Bertozzi, C. R.; Francis,
M. B. Angew. Chem., Int. Ed. Engl. 2006, 45, 896–901.
(24) Hsiao, S. C.; Crow, A. K.; Lam, W. A.; Bertozzi, C. R.; Fletcher,
D. A.; Francis, M. B. Angew. Chem., Int. Ed. Engl. 2008, 47, 8473–
7.
(25) Fan, R.; Vermesh, O.; Srivastava, A.; Yen, B. K. H.; Qin, L.; Ahmad,
H.; Kwong, G. A.; Liu, C. C.; Gould, J.; Hood, L.; Heath, J. R. Nat.
Biotechnol. 2008, 26, 1373–1378.
(26) Ramachandiran, V.; Grigoriev, V.; Lan, L.; Ravkov, E.; Mertens, S. A.;
Altman, J. D. J. Immunol. Methods 2007, 319, 13–20.
(27) Cameron, T. O.; Cochran, J. R.; Yassine-Diab, B.; Sekaly, R. P.; Stern,
L. J. J. Immunol. 2001, 166, 741–745.
(28) Reznik, G. O.; Vajda, S.; Cantor, C. R.; Sano, T. Bioconj. Chem. 2001,
12, 1000–1004.
(29) Green, N. M. Methods Enzymol. 1970, 18, 418–424.
(30) Johnson, L. A.; Heemskerk, B.; Powell, D. J.; Cohen, C. J.; Morgan,
R. A.; Dudley, M. E.; Robbins, P. F.; Rosenberg, S. A. J. Immunol.
2006, 177, 6548–6559.
(31) Nishimura, M. I.; Avichezer, D.; Custer, M. C.; Lee, C. S.; Chen, C.;
Parkhurst, M. R.; Diamond, R. A.; Robbins, P. F.; Schwartzentruber,
D. J.; Rosenberg, S. A. Cancer Res. 1999, 59, 6230–6238.
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hybridized cognate p/MHC but not to spots printed with the
noncomplementary sequences B and C (Figure 3A). The mean
binding capacity calculated from three spots (∼600 µm) was
∼1486 ( 62 JurkatR-Tyr T cells.
To illustrate the multiplexing capability of NACS, MART-
1, tyrosinase, and NY-ESO-1 ssDNA-p/MHC tetramers encoded
to DNA sequences A, B, and C, respectively, were combined
and assembled simultaneously to a three element cDNA micro-
array (strands A′, B′, and C′). A 1:1:1 mixed population of
JurkatR-MART-1, JurkatR-Tyr and JurkatR-NY-ESO-1 (Jurkat human T
cells transduced with the TCR32 specific for NY-ESO-1) cells
prestained with lipophilic dyes (red, green, and blue, respec-
tively) was applied to the array and localized into alternating
columns (Figure 3B). Minimal cross-reactivity was observed.
The average density of spots was about a factor of 3 less than
that of homogeneous sorting (440 ( 28 T cells/spot).
To determine the limit of detection, target populations of
JurkatR-Tyr cells were spiked in at 10%, 1%, and 0.1% into wild
type (w.t.) Jurkat cells and sorted (Figure 4A). The T cell capture
density per spot per species for each mixture was enumerated
and averaged (Figure 4B). The number of nonspecific w.t. Jurkat
cells that adhered to the array was constant throughout all
dilutions while the number of JurkatR-Tyr T cells captured per
spot decreased linearly in relation to the fractional composition
of JurkatR-Tyr cells with a detection limit that was ∼ 1 in 1000
cellssa limit that corresponds well to the total number of cells
that can be captured per spot. Thus, the sensitivity of this
approach is strictly a geometric constraint since antigen-specific
T cells that settle on inert areas cannot sample and bind to their
cognate p/MHC tetramer. The sensitivity can be improved by
increasing the size of the capture region (i.e., increase spot
diameter and/or incorporate spot redundancy) or by reducing
inert regions (i.e., increase printing density). It should be noted,
however, that the sensitivity of this approach cannot be increased
without limiting scalability. Since spot diameters are required
to be sufficiently large to detect a population at low frequency,
this sets an upper bound on the number of distinct spots that
can be patterned on a substrate. In the current instance, 600
µm spots are printed in 12 by 12 grids (∼1 in2), enabling the
potential identification of 144 distinct antigen-specificities
g0.1% from 106 T cells (106 cells is typically required to cover
a 1 in2 region). In order to detect target populations below 0.1%
without decreasing multiplexing, p/MHC-specific enrichment
strategies (e.g., magnetic bead-based schemes33) can be imple-
mented prior to cell sorting. Lastly, the recovery of this
techniquesdefined as the total number of antigen-specific T cells
captured as a fraction of the number of T cells applied to the
arraysis low relative to other sorting technologies like FACS
and bead-based schemes. Typical T cell recovery for NACS is
e20%.34 In comparison, fluorescent-based sorting techniques
like FACS have high recoveries, since each stained T cell can
be identified individually by the cytometer and sorted from the
null population. The recovery (as well as sensitivity) of NACS
will likely be improved by circulating T cells over the p/MHC
array with agitation or with integrated microfluidic devices to
allow T cells to sample the entire array.
Selective Release of Immobilized T cells with Restriction
Endonucleases. Antigen-specific T cells immobilized onto glass
are immediately available for secondary assays, since many
assays such as immunohistochemistry (IHC), fluorescent in situ
hybrization (FISH) and cytokine secretion assays6,8 are tradi-
tionally performed or are compatible with cells localized to a
substrate. However, several other relevant assays, such as those
designed to assess T cell phenotype or functional status like
genomic/mRNA analysis or simply, further culture for pheno-
typic enrichment would require a method for releasing the
(32) Wargo, J. A.; Robbins, P. F.; Li, Y.; Zhao, Y.; El-Gamil, M.;
Caragacianu, D.; Zheng, Z.; Hong, J. A.; Downey, S.; Schrump, D. S.;
Rosenberg, S. A.; Morgan, R. A. Cancer Immunol. Immunother. 2009,
58, 383–394.
(33) Moon, J. J.; Chu, H. H.; Pepper, M.; McSorley, S. J.; Jameson, S. C.;
Kedl, R. M.; Jenkins, M. K. Immunity 2007, 27, 203–213.
(34) For a typical homogeneous sorting experiment, 106 T cells are applied
to an array containing 144 spots. Each spot can bind to ∼1486 ( 62
T cells. The recovery, R, is calculated as R ) 100% × (144 × 1486)/
106 ≈ 20%. The recovery is valid even with heterogeneous samples
(e.g., 1:1:1 mixture of three antigen-specific T cell populations) when
the entire array is used to sort a single target population (R ) 100%
× (144 spots × 661)/(3.3 × 105) ≈ 20%). For multiplexed experi-
ments, R is proportional to the fraction of the 144 spots dedicated for
cell capture.
Figure 2. Comparison of NACS versus spotted p/MHC arrays. (A) Brightfield and fluorescent images of JurkatR-MART-1 T cells captured on various model
substrates. (B) Quantification of T cell capture efficiencies (hydrophobic surface was excluded because signal:noise e 1). Each data point was derived from
three representative spots.
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captured cells. Any release scheme should ideally be selective
for given cell types. For NACS, we explored whether the DNA
tethers could be selectively cleaved by exploiting the sequence
specificity of restriction endonucleases. We integrated unique
Figure 3. Mulitplexed nucleic acid cell sorting of antigen-specific T cells. (A) Tyrosinase p/MHC tetramer conjugated to ssDNA sequence A′ was hybridized
to an array printed with DNA complement strand A and noncomplement strands B and C (dashed circles). JurkatR-Tyr cells were localized to spot A only.
(B) A 1:1:1 mixture of JurkatR-MART-1 (red), JurkatR-Tyr (green) and JurkatR-NY-ESO-1 cells was selectively sorted on an array hybridized with MART-1, tyrosinase,
and NY-ESO-1 p/MHC ssDNA-tetramers (top left). The remaining three panels are representative images of spots A, B, and C.
Figure 4. NACS limit of detection. (A) JurkatR-Tyr cells (red) were serially diluted in wild type (WT) Jurkat cells (green) at frequencies 50%, 10%, 1%, and
0.1% and detected by NACS. (B) The average number of JurkatR-Tyr cells and WT Jurkat cells per dilution per spot plotted in a histogram.
J. AM. CHEM. SOC. 9 VOL. 131, NO. 28, 2009 9699
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restriction sites to each DNA sequence employed for cell sorting,
and found that the adhesion of different populations of antigen-
specific T cells could, in fact, be independently controlled
(Figure 5A). JurkatR-MART-1 and JurkatR-Tyr cells prestained with
lipophilic dyes (red and green respectivey) were sorted on an
array printed with DNA sequences AEcoRI and BBamHI (Figure
5Bi). These oligonucleotides were modified by incorporating 6
bp restriction sites specific for endonucleases EcoRI and BamHI
respectively. After T cell immobilization, the array was treated
with BamHI which cleaved the BBamHI spots and selectively
released the bound JurkatR-Tyr cells (Figure 5Bii). Conversely,
on a separate but identically sorted array, JurkatR-MART-1 cells
were released after treatment with EcoRI (Figure 5Biii). A
second round of enzymatic treatment with the remaining
endonuclease [EcoRI to state (ii) or BamHI to state (iii)]
removed the remaining adherent cells (Figure 5BiV). Alterna-
tively, all captured cells (i) could be released nonselectively in
a single step with the addition of DNase.
NACS Sorting of Endogenous Primary Human T Cells.
Detection of primary human T cells isolated from peripheral
blood is generally more demanding than cultured cell lines
because a single population of antigen-specific T cells is present
within a large background of differing blood cells and of T cells
expressing monoclonal and polyclonal TCRs of diverse speci-
ficities. In addition, these T cells would be expressing endog-
enous levels of TCR. We explored whether the same attributes
of NACS that were found in the above examples would apply
equally to endogenous primary human T cells. Frozen white
blood cell samples from patient NRA13 were CD8+ enriched
and applied to a Cytomegalovirus (CMV) and Epstein-Barr
virus (EBV) p/MHC array. T cells were captured within the
EBV regions only (Figure 6A). NRA13 CD8+ cells were
verified by flow cytometry to be ∼5% EBV-specific and ∼0%
CMV-specific (Figure S4A of the Supporting Information). The
registry of the array was determined with the addition of
A′-cy3 (red) and B′-cy5 (blue) conjugates.
Figure 5. Programmed release of sorted T cells by endonuclease cleavage. (A) DNA microarrays were printed with orthogonal sequences containing EcoRI
and BamHI restriction sites. (B) Fluorescent images of JurkatR-MART-1 (red) and JurkatR-Tyro (green) cells captured on p/MHC array (i) and after treatment with
BamHI (ii) or EcoRI (iii). Only cells localized to DNA spots containing the target restriction sequence were released. A second round of enzymatic treatment
released the remaining bound cells (iV, image representative of BamHI to EcoRI cleavage).
Figure 6. NACS sorting of endogenous primary human T cells specific for Epstein-Barr virus and Cytomegalovirus. (A) CD8+ T cells from patient NRA
13 were captured on EBV p/MHC spots and no T cells were captured on CMV spots (left panel). The right two panels are representative images after the
cells were stained with fluorescent EBV (blue) and CMV p/MHC tetramers (red). (B) T cells detected from a 1:1 mixture of NRA11 and NRA 13 (left panel)
were verified to be specific for EBV and CMV (right panels). (C) Mixtures of ∼0.4%, 0.2% and 0.1% EBV-specific T cell populations (upper panels) were
detected via NACS (bottom panels). Populations of EBV-specific T cells are marked with red arrows and nonspecific cells are marked with black arrows.
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For multiplexed detection, a 1:1 mixture of EBV-specific and
CMV-specific CD8+ T cells was produced by combining
NRA13 T cells with CMV-specific T cells from patient NRA11
(Figure S4B of the Supporting Information). Following cell
sorting and fluorescent p/MHC tetramer staining, the populations
were complementary stained for the appropriate antigen-
specificity (Figure 6B). The detection limit of antigen-specific
T cells was evaluated from using serially diluted mixtures of
EBV-specific T cells (∼0.4%, 0.2%, and 0.1% by FACS) that
were probed on an array. Isolated hits were resolved in
frequencies as low as ∼0.1% (Figure 6C, red arrows). The
number of unstained cells within the capture regions (black
arrow) was constant throughout all dilutions (∼1-2 cells/spot)
and likely represents the level of background from nonspecific
interactions. It should be noted that while we incorporated
fluorescent p/MHC tetramer staining after T cell immobilization
for illustrative purposes, the specificity of the captured cells
could be determined solely from the registry of the array.
Persistence of MART-1 Specific, TCR-Engineered Human
T Cells in Vivo. One important potential application of NACS
is to utilize the technique for monitoring cancer patients that
are undergoing a particular type of immunotherapy that involves
TCR engineering of peripheral blood mononuclear cells
(PBMCs). This is an emerging clinical approach to rapidly
generate large numbers of tumor antigen-specific T cells. In
particular, a cancer patient’s T cells are collected, genetically
modified to express a TCR specific for a desired cancer antigen,
and then they are introduced back into the patient as a cancer
therapy. After reinfusion into the patient, the modified T cells
can subsequently traffic to and engage with cancer cells,
promoting tumor regression in a subset of patients with
metastatic cancers. This type of directed cell therapy is utilized
primarily in patients with melanoma (skin cancer), but also for
other cancers.35,36 This approach is called adoptive cell transfer
(ACT). We monitored the presence and abundance of TCR-
engineered T cells in peripheral blood of a patient undergoing
ACT. White blood cells were collected from patient F5-1 with
metastatic melanoma. After in vitro expansion and TCR
transduction, the cells were >80% specific for the MART-1
p/MHC tetramer (Figure 7A). These cells were subsequently
infused into patient F5-1 and the presence and persistence of
MART-1-specific T cells in the peripheral blood was monitored
by NACS at days 0 (prior to infusion), 9, 14, and 30 (Figure
7B). MART-1-specific T cells were not detectable in preinfusion
samples from the patient but they were detectable at all
subsequent time points. This is represented as a gradual rise in
the abundance of MART-1-specific T cells until day 30 (left
axis). In comparison, the frequency of MART-1-specific T cells
detected by flow cytometry spiked initially before decreasing
and finally increasing by day 30 (right axis).
The abundance of TCR-engineered T cells, as measured by
NACS, was generally correlated with parallel measurements
using flow cytometry. The prospect of array-based T cell
detection schemes for experimental cancer immuno-therapies
such as ACT will likely increase as more cancer associated
antigens are identified and targeted. For example, more than
50 different melanoma associated antigens have thus far been
characterized,37,38 and this means that more T cells types are
likely to be employed for future therapies.36,39,40 However, the
desire to probe larger sets of cancer-associated antigens will be
compounded by the amount of sample that can be practically
collected from a patient. NACS appears to provide a feasible
approach toward carrying out the highly multiplexed cellular
measurements that will eventually be required as ACT-like
therapies move forward.
Conclusions
We have described a method for generating robust and
modular p/MHC arrays for high efficiency T cell sorting. The
inclusion of a larger set of orthogonal DNA sequences20,25 will
enable the modular assembly of higher order p/MHC arrays for
T cell screening experiments (e.g., one working set of DNA
sequences can be used interchangeably to generate any com-
bination of p/MHC arrays). This would find immediate utility
(35) Schumacher, T. N. Nat. ReV. Immunol. 2002, 2, 512–519.
(36) Morgan, R. A.; Dudley, M. E.; Wunderlich, J. R.; Hughes, M. S.;
Yang, J. C.; Sherry, R. M.; Royal, R. E.; Topalian, S. L.; Kammula,
U. S.; Restifo, N. P.; et al. Science 2006, 314, 126–129.
(37) Rosenberg, S. A. Immunity 1999, 10, 281–287.
(38) Rosenberg, S. A. Nature 2001, 411, 380–384.
(39) Dudley, M. E.; et al. Science 2002, 298, 850–854.
(40) Hunder, N. N.; Wallen, H.; Cao, J.; Hendricks, D. W.; Reilly, J. Z.;
Rodmyre, R.; Jungbluth, A.; Gnjatic, S.; Thompson, J. A.; Yee, C.
N. Engl. J. Med. 2008, 358, 2698–2703.
Figure 7. Monitoring the presence of infused MART-1-specific, TCR-engineered T cells. (A) Flow cytometry plots (top panels) and NACS (bottom panels)
monitoring the transduction of T cells with a MART-1-specific TCR. (B) Blood cells from patient F5-1 were collected at days 0, 9, 14, and 30 after
infusion. The abundance of MART-1-specific T cells was monitored by NACS (left axis) and flow cytometry (right axis).
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in the field of TCR peptide epitope discovery where recently,
novel antigen peptides were discovered via high-throughput
CD8+ screening experiments utilizing multicolor flow cytom-
etry in mice and humans41,42 (as many as 2,000 distinct p/MHC
tetramers were prepared and tested). NACS arrays have the
potential to streamline such experiments. Although traditional
methods of producing single p/MHC monomers are time and
labor intensive, recent reports using conditional peptide ex-
change technology enables the relatively straightforward con-
struction of 1000 element p/MHC libraries rapidly.41-43 The
integration of NACS with these peptide exchange technologies
is a realistic option.
We have demonstrated a number of advantages of the NACS
platform. It significantly outperforms literature approaches that
utilize surface-bound p/MHC tetramers to capture cells. It is
simple and inexpensive to implement since cell sorting is
performed on glass substrates prepared via traditional DNA
printing technologies. In addition, sorted cells may be selectively
released, which should permit for the deployment of a host of
bioanalytical methods on NACS sorted cells. We envision that
NACS will find uses beyond multiplexed sorting of T cells based
on TCR specificity. The principal components of this platforms
streptavidin-cysteine core and orthogonal single-stranded DNA
sequencesswere rationally developed to enable oriented cou-
pling and spatial addressing. Thus this platform is amenable to
any family of binding proteins or small molecule binders labeled
with biotin. The increase in avidity of p/MHC tetramers over
monomers as a consequence of the valency of SA should
likewise extend to other capture agents, making it feasible to
generate cellular arrays with probes ranging from high to
moderate affinities like antibodies, aptamers, or peptides.
Experimental Section
Microarray Fabrication. All DNA strands were purchased from
IDT. DNA microarrays were printed by the microarray facility at
the Institute for Systems Biology (ISB--Seattle, WA) on amine-
coated glass slides (GAPS II, Corning) in identical triplicate 12 ×
12 arrays containing alternative rows of A, B and C spots, or AEcoRI
and BBamHI with a SMPXB15 pin (Arrayit). Sequences for all strands
can be found at Supporting Information Table 1 online.
Production of ssDNA-SAC conjugates. The pET-3a plasmid
containing the SAC gene was a kind gift from Takeshi Sano
(Harvard Medical School). The expression of SAC was performed
according to previously published protocols.44 Prior to conjugation,
stock SAC was buffer exchanged to PBS containing 5 mM Tris(2-
Carboxyethyl) phosphine Hydrochloride (TCEP) using zeba de-
salting columns (Pierce). MHPH (3-N-Maleimido-6-hydrazini-
umpyridine hydrochloride, Solulink) in DMF was added to SAC
at a molar excess of 300:1. In parallel, SFB in DMF (succinimidyl
4-formylbenzoate, Solulink) was added in a 40:1 molar excess to
5′aminated oligos. The mixtures were reacted at room temperature
(RT) for 3-4 h before buffer exchanged to citrate (50 mM sodium
citrate, 150 mM NaCl, pH 6.0) using zeba columns. The SFB-
labled oligos were combined in a 20:1 molar excess with the
derivatized SAC and incubated overnight at RT. Unreacted oligos
were removed using a Pharmacia Superdex 200 gel filtration column
at 0.5 mL/min isocratic flow of PBS. Fractions containing the SAC-
oligo conjugates were concentrated using 10K mwco concentration
filters (Millipore).
Preparation of T cells. The cDNA from the alpha and beta
chains of a TCR specific for tyrosinase368-376 was a kind gift from
Michael I. Nishimura (Medical University of South Carolina,
Charleston, SC). The alpha and beta chains were cloned into a
lentiviral vector where both transgenes were linked by a 2A self-
cleaving sequence as described.45 Concentrated supernatant from
this lentiviral vector was used to infect Jurkat cells to generate
JurkatR-Tyro cells. The MSGV1-F5AfT2AB retroviral vector express-
ing the F5 MART-1 TCR was a kind gift from Steven A. Rosenberg
and Richard Morgan (Surgery Branch, National Cancer Institute
Bethesda, MD). The MSGV1-F5AfT2AB retroviral supernatant was
used to infect Jurkat cells to generate the JurkatR-MART-1 cell line.
The JurkatR-NY-ESO-1 cell line was a generous gift from Robert Prins
(UCLA). To generate primary human T cell cultures expressing
the F5 MART-1 TCR, PBMCs obtained from leukapheresis were
activated for 48 h with 50 ng/mL of OKT3 (muromonab antihuman
CD3 antibody, Ortho-Biotech, Bridgewater, NJ) and 300 U/ml of
IL-2 (adesleukin, Novartis, Emeryville, CA). MSGV1-F5AfT2AB
retrovirus supernatant was applied to retronectin-coated wells
(Takara Bio Inc., Japan). Then activated PBMC in RPMI plus 5%
human AB serum supplemented by 300 IU of IL-2 were added to
these wells and incubated at 37 °C overnight at 5% CO2. On the
following day, PBMC are transferred to a second set of precoated
retronectin retroviral vector tissue culture plates and incubated at
37 °C overnight at 5% CO2. Cells were subsequently washed and
resuspended in culture media described above. Frozen leukapheresis
fractions from patients NRA11, NRA 13 (UCLA IRB#03-12-023)
and F5-1 (UCLA IRB #08-02-020-02A) were thawed and
incubated overnight in RPMI supplemented with 10% human AB
serum and 1% penicillin, streptomycin, and amphotericin (Omega
Scientific). F5-1 cells were used immediately following incubation.
NRA11 and NRA13 samples were CD8+ enriched (anti-CD8
microbeads, Miltenyi Biotech) using an AutoMACS machine
according to the manufacturer’s instructions. Following separation,
the cells were kept at in RPMI-humanAB media containing 30 U
IL2/mL.
Cell Sorting Methods. The HLA-A*0201 restricted MHC class
I monomers loaded with tyrosinase369-377 (YMDGTMSQV) and
MART-126-35 (ELAGIGILTV), and NY-ESO-1157-165 (SLLM-
WITQC) were produced in house according to previous published
protocols.46 HLA-A*0201-restricted EBV BMLF1259-267 (GLCTL-
VAML), CMV pp65495-503 (NLVPMVATV), murine H-2Kb/-
OVA257-264 (SIINFEKL), and murine H-2Db/-gp10025-33 (KVPRN-
QDWL) as well as all fluorescent HLA-A*0201 tetramers were
purchased from Beckman Coulter. Lipophilic cell membrane
staining dyes DiO, DiD, and DiL were purchased from Invitrogen.
Prior to experiments, microarray slides were blocked to prevent
nonspecific cell binding with 1 mg/mL PEG-NHS ester (Sunbio)
in PBS for 2 h at RT. 4-fold molar excess of p/MHC monomers
were combined with ssDNA-SAC at 37 °C for 20 min ssDNA-p/
MHC tetramers were hybridized to DNA arrays for 1 h at 37 °C in
200 µL media and rinsed with 3% FBS in PBS. T cells (106 /100
µL media) were incubated on the array at 37 °C for 30 min. The
arrays were rinsed with 3% FBS in PBS and cell capture visualized
via brightfield (Nikon Eclipse TE2000) and/or confocal microscropy
(Nikon E800). Post T cell capture p/MHC tetramer staining was
done by incubating the array with 200 µL of media containing
fluorescent p/MHC tetramer along with fluorescent cDNA
(Cy5-A’ and/or Cy3-B’). The arrays were rinsed with 3% FBS in
(41) Toebes, M.; Coccoris, M.; Bins, A.; Rodenko, B.; Gomez, R.;
Nieuwkoop, N. J.; van de Kasteele, W.; Rimmelzwaan, G. F.; Haanen,
J.; Ovaa, H.; Schumacher, T. N. Nat. Med. 2006, 12, 246–251.
(42) Grotenbreg, G. M.; Roan, N. R.; Guillen, E.; Meijers, R.; Wang, J.;
Bell, G. W.; Starnbach, M. N.; Ploegh, H. L. Proc. Natl. Acad. Sci.
U.S.A. 2008, 105, 3831–3836.
(43) Bakker, A. H.; Hoppes, R.; Linnemann, C.; Toebes, M.; Rodenko,
B.; Berkers, C. R.; Hadrup, S. R.; van Esch, W. J.; Heemskerk, M. H.;
Ovaa, H.; Schumacher, T. N. Proc. Natl. Acad. Sci. U.S.A. 2008, 105,
3825–3830.
(44) Sano, T.; Cantor, C. R. Proc. Natl. Acad. Sci. U.S.A. 1990, 87, 142–
146.
(45) Szymczak, A. L.; Workman, C. J.; Wang, Y.; Vignali, K. M.;
Dilioglou, S.; Vanin, E. F.; Vignali, D. A. A. Nat. Biotechnol. 2004,
22, 589–594.
(46) Garboczi, D. N.; Hung, D. T.; Wiley, D. C. Proc. Natl. Acad. Sci.
U.S.A. 1992, 89, 3429–3433.
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PBS prior to imaging. For selective T cell release experiments, three
identical arrays were used to immobilize cells. Treatment with
EcoRI, BamHI, or DNase was in RPMI media for 1-2 h at 37 °C.
DNase was purchased from Sigma, all other enzymes from
NEbiolabs.
For p/MHC comparative studies, SuperEpoxy and SuperProtein
(representing covalent and hydrophobic surfaces respectively) were
purchased from Arrayit (Sunnyvale, CA). Amine GAPS II slides
(electrostatic) were purchased from Corning. Polycarboxylate
hydrogel (hydrophilic) slides were purchased from XanTec (Ger-
many). Fluorescent MART-1 tetramers were printed according to
manufacturer’s instructions for each slide. Cell sorting images were
quantified with ImageJ (NIH) and fitted to the Hill Function (NACS
n ) 2, R2)0.95, Covalent n ) 2.1, R2 )0.97) with Origin
(OriginLab, MA).
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